• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

International Collaboration Study on the Racial Difference in Coronary Vasospasm

Research Project

Project/Area Number 15256003
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section海外学術
Research Field Circulatory organs internal medicine
Research InstitutionTohoku University (2005)
Kyushu University (2003-2004)

Principal Investigator

SHIMOKAWA Hiroaki  Tohoku University, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (00235681)

Co-Investigator(Kenkyū-buntansha) KOIKE Jouji  Kyushu University Hospital, Assistant, 病院・助手 (90325522)
ITO Akira  Kyushu University Hospital, Assistant Prof., 病院・講師 (00360868)
Project Period (FY) 2003 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥34,840,000 (Direct Cost: ¥26,800,000、Indirect Cost: ¥8,040,000)
Fiscal Year 2005: ¥7,670,000 (Direct Cost: ¥5,900,000、Indirect Cost: ¥1,770,000)
Fiscal Year 2004: ¥9,360,000 (Direct Cost: ¥7,200,000、Indirect Cost: ¥2,160,000)
Fiscal Year 2003: ¥17,810,000 (Direct Cost: ¥13,700,000、Indirect Cost: ¥4,110,000)
Keywordscoronary vasospasm / vasospastic angina / Rho-kinase / genetic analysis / international collaboration
Research Abstract

1. We have demonstrated that Rho-kinase is substantially involved in the molecular mechanism for coronary vasospasm.
2. We have demonstrated that Rho-kinase is substantially involved in the molecular mechanism fornot only epicardial vasospasm but also microvascular vasospasm.
3. We have demonstrated that long-term inhibition of Rho-kinase causes a regression of both coronary arteriosclerosis and coronary vasospasm.
4. We have identified the novel SNP of Rho-kinase, G930T in its catalytic domain and have demonstrated that this SNP is associated with an enhancement of Rho-kinase activity.
5. We have demonstrated that the frequency of the T930allele is significantly higher in patients with coronary vasospasm than in those without the spasm or controls. We have further demonstrated that this SNP is not noted in Caucasian patients with angina pectoris.
6. Taken together, those results suggest that the relatively higher frequency of G930T could explain, at least in part, the racial difference in the prevalence of coronary vasospasm between Japanese and Caucasian populations.
7. We have published the English review regarding the therapeutic importance of Rho-kinase.

Report

(4 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report
  • Research Products

    (26 results)

All 2005 2004 2003 Other

All Journal Article (20 results) Book (2 results) Publications (4 results)

  • [Journal Article] Rho-kinase is an important therapeutic target in cardiovascular medicine.2005

    • Author(s)
      Shimokawa H, Takeshita A.
    • Journal Title

      Arterioscler Thromb Vasc Biol. 25

      Pages: 1767-1775

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Beneficial effects of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microcirculation in vivo.2005

    • Author(s)
      Yada T, Shimokawa H, et al.
    • Journal Title

      J Am Coll Cardiol. 45

      Pages: 599-607

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Rho-kinase is an important therapeutic target in cardiovascular medicine.2005

    • Author(s)
      Shimokawa H, Takeshita A.
    • Journal Title

      Arterioscler Thromb vase Biol. 25

      Pages: 1767-1775

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Rho-kinase is an important therapeutic target in cardiovascular medicine. (Review)2005

    • Author(s)
      Shimokawa H, Takeshita A.
    • Journal Title

      Arteriosclerosis, Thrombosis, and Vascular Biology 25

      Pages: 1767-1775

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.2005

    • Author(s)
      Fukumoto Y, Shimokawa H, et al.
    • Journal Title

      Heart 91

      Pages: 391-392

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Beneficial effects of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microcirculation in vivo.2005

    • Author(s)
      Yada T, Shimokawa H, et al.
    • Journal Title

      Journal of American College of Cardiology 45

      Pages: 599-607

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Prostacyclin does not inhibit Rho-kinase : An implication for the treatment of pulmonary hypertension.2005

    • Author(s)
      Abe K, Shimokawa H, et al.
    • Journal Title

      Journal of Cardiovascular Pharmacology 45

      Pages: 120-124

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure.2005

    • Author(s)
      Kishi T, Hirooka Y, Shimokawa H, et al.
    • Journal Title

      Circulation 111

      Pages: 2741-2747

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells.2004

    • Author(s)
      Hiroki J, Shimokawa H, et al.
    • Journal Title

      Biophys Biochem Res Commun. 326

      Pages: 154-159

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase.2004

    • Author(s)
      Oi K, Shimokawa H, et al.
    • Journal Title

      Arterioscler Thromb Vasc Biol. 24

      Pages: 918-922

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase.2004

    • Author(s)
      Oi K, Shimokawa H, et al.
    • Journal Title

      Arterioscler Thromb Yasc Biol. 24

      Pages: 918-922

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries -Involvement of multiple mechanism2004

    • Author(s)
      Matsumoto Y, Shimokawa H, et al.
    • Journal Title

      Arteriosclerosis, Thrombosis, and Vascular Biology 24

      Pages: 181-186

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice.2004

    • Author(s)
      Hattori T, Shimokawa H, et al.
    • Journal Title

      Circulation Research 94

      Pages: 46-52

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.2004

    • Author(s)
      Abe K, Shimokawa H, et al.
    • Journal Title

      Circulation Research 94

      Pages: 385-393

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.2004

    • Author(s)
      Hattori T, Shimokawa H, et al.
    • Journal Title

      Circulation 109

      Pages: 2234-2239

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase.2004

    • Author(s)
      Oi K, Shimokawa H, et al.
    • Journal Title

      Arteriosclerosis, Thrombosis, and Vascular Biology 24

      Pages: 918-922

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery.2004

    • Author(s)
      Inokuchi K, Shimokawa H, et al.
    • Journal Title

      Journal of Cardiovascular Pharmacology 44

      Pages: 437-445

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with angina and normal coronary angiograms.2003

    • Author(s)
      Mohri M, Shimokawa H, et al.
    • Journal Title

      J Am Coll Cardiol. 41

      Pages: 15-19

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] A comprehensive analysis of a missense mutation in the Rho-kinase gene that potentially causes coronary vasospastic ischemic heart disease in Japanese.

    • Author(s)
      Kamiunten H, Shimokawa H, et al.
    • Journal Title

      Circulation. (Publication is in preparation)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] A comprehensive analysis of a missense mutation in the Rho-kinase gene that potentially causes coronary vasospastic ischemic heart disease in Japanese.

    • Author(s)
      Kamiunten H, Shimokawa H, et al.
    • Journal Title

      Circulation. (Publication is in preparation)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Book] EBM循環器疾患の治療、冠攣縮性狭心症2005

    • Author(s)
      伊藤昭, 下川宏明
    • Related Report
      2005 Annual Research Report
  • [Book] Rho・Rhoキナーゼ2004

    • Author(s)
      東みどり子, 下川宏明
    • Publisher
      メディカルレビュー社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Publications] Mohri M, Shimokawa H, et al.: "Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with angina and normal coronary angiograms"Journal of American College of Cardiology. 41. 15-19 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Kandabashi T, Shimokawa H, et al.: "Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm"Arteriosclerosis, Thrombosis, and Vascular Biology. 23. 2209-2214 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Higashi M, Shimokawa H, et al.: "Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo"Circulation Research. 93. 767-775 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hattori T, Shimokawa H, et al.: "Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice"Circulation Research. 94. 46-52 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi